Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.71 Million CAD | 25.49% |
| 2022 | -3.63 Million CAD | -326.75% |
| 2021 | -852.81 Thousand CAD | -522.72% |
| 2020 | -136.95 Thousand CAD | -190108.33% |
| 2019 | -72.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -231.46 Thousand CAD | -13.87% |
| 2024 Q1 | -203.26 Thousand CAD | 63.62% |
| 2023 Q2 | -908.4 Thousand CAD | 13.75% |
| 2023 Q4 | -558.68 Thousand CAD | -49.55% |
| 2023 FY | -2.94 Million CAD | 19.21% |
| 2023 Q3 | -373.57 Thousand CAD | 58.88% |
| 2023 Q1 | -1.05 Million CAD | -4.4% |
| 2022 Q1 | -821.05 Thousand CAD | 65.66% |
| 2022 FY | -3.63 Million CAD | -326.75% |
| 2022 Q4 | -1 Million CAD | -0.66% |
| 2022 Q3 | -1 Million CAD | -24.2% |
| 2022 Q2 | -807 Thousand CAD | 1.71% |
| 2021 Q2 | -95.65 Thousand CAD | -37.91% |
| 2021 Q1 | -69.36 Thousand CAD | 48.68% |
| 2021 FY | -852.81 Thousand CAD | -522.72% |
| 2021 Q4 | -2.39 Million CAD | -1962.38% |
| 2021 Q3 | -115.94 Thousand CAD | -21.22% |
| 2020 FY | -136.95 Thousand CAD | -190108.33% |
| 2020 Q3 | -45.78 Thousand CAD | 0.0% |
| 2020 Q4 | -135.15 Thousand CAD | -195.2% |
| 2019 FY | -72.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AI/ML Innovations Inc. | -1.66 Million CAD | -62.88% |
| Diagnamed Holdings Corp. | -1.17 Million CAD | -130.267% |
| nDatalyze Corp. | -316.56 Thousand CAD | -756.639% |
| Treatment.Com International Inc. | -2.32 Million CAD | -16.539% |
| Unidoc Health Corp. | -2.2 Million CAD | -23.227% |